Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1298
Selected: 0
NCT IDTitle
NCT00533442Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients
NCT00637143Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF)
NCT02563782Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD
NCT01430078A Study to Assess the Bioavailability of ASP015K
NCT01232413A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy Subjects
NCT02526979A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)
NCT01028950YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness
NCT02377791Impact of CYP3A5 Gene Polymorphisms on Tacrolimus Concentrations and Outcomes in Thai Transplant Recipients
NCT03241550A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
NCT01995513Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients
NCT02847091Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy
NCT00534508Distribution of Tacrolimus in Skin, Atopic Dermatitis
NCT02052310Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis Participants
NCT02294461An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants
NCT02981459Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women
NCT06130995Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
NCT04003402A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult Subjects
NCT00801957Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis
NCT00853671Myocardial Stress Perfusion Imaging With Dual Source CT
NCT06902545A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.
NCT01908829A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
NCT00368706A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients
NCT01675518A Study to Assess the Safety, Pharmacological Effect and Plasma Concentration of ASP7991 After Single Oral Administration to Healthy Volunteers
NCT00720408A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.
NCT02634489EC905 Pharmacokinetic Profile Study
NCT01901120Long-Term Specified Drug Use-results Survey of Betanis Tablets
NCT01209988Impact of Tamsulosin on Voiding Patterns Following Early Catheter Removal After Robot-assisted Laparoscopic Radical Prostatectomy
NCT01478503To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly Females
NCT01096862A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Psoriasis
NCT00376337Micafungin Salvage Mono-therapy in Invasive Aspergillosis
NCT01967095Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer
NCT01016054A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer
NCT05199051A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD and/or FLT3-TKD Relapse/Refractory (R/R) AML
NCT01781195Delayed CNI-based Immunosuppression With Advagraf After MELD-based Liver Transplantation
NCT02610062A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)
NCT04742517A Study of MA-0217 (ASP1128) in Healthy Adult Subjects and Healthy Elderly Subjects
NCT00850746A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults
NCT01089517A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration
NCT02169713Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects
NCT00535691Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis
NCT04408820Post-marketing Surveillance of EVRENZO® Tablets (Roxadustat) in Patients With Renal Anemia
NCT02372578Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy
NCT05083884A Survey About Hot Flashes in Women Going Through the Menopause
NCT00859833Effects of Body Mass Index on the Hyperemic Response to Regadenoson
NCT03660059A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX)
NCT01771705NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients
NCT01092624Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal Prolapse
NCT06394570Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer
NCT00936910Antifungal Locks to Treat Fungal-related Central Line Infections
NCT06906822PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients